A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

CAR T cells are patient-derived, genetically engineered immune cells. They are "living drugs" and constitute a milestone in modern medicine. Equipping T cells, a key cell type of the immune system, ...

In a recent study, researchers identified key genetic factors that enhance tea plant resistance to Colletotrichum ...

New research has identified genetic modifications that may increase the effectiveness of immunotherapy for multiple myeloma, ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy of chimeric antigen receptor (CAR)-T cell treatment ...

In Burkina Faso, the Target Malaria project, a global research consortium aiming to use genetically modified mosquitoes to ...

The investment from Brown parents Giammaria and Sabrina Giuliani will support scholars seeking to unlock the potential of RNA ...

Texas-based company, Colossal Biosciences, announced groundbreaking advances in avian cloning last week, along with a new funding round.

Researchers from NYU Abu Dhabi and the Tandon School of Engineering spearheaded the development of an ingestible device with LED light technology that could transform the way doctors examine and treat ...

Reliable detection of NGT products is possible and essential for transparency and consumer trust, say researchers ...